SCHEMBL20466232

SCHEMBL20466232

CC(=O)SCCCCCC(=O)OCCO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.47
MGLL Q99685 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
DNM1 Q05193 1/20 0.40
EPHX2 P34913 1/20 0.36
ACHE P22303 2/20 0.36
PAM P19021 2/20 0.36
KDM4E B2RXH2 2/20 0.36
DUSP3 P51452 1/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20466247 0.89 EPHX2 (0.46) DGKAMGLLHDAC3HDAC4HDAC1
SCHEMBL823903 0.87 EPHX2 (0.44) DGKAMGLLHDAC3HDAC4HDAC1
SCHEMBL8719563 0.85 MGLL (0.39) DGKAMGLLDNM1ACHETSHR
SCHEMBL20466249 0.83 DGKA (0.49) DGKAHDAC3HDAC4HDAC1HDAC7
SCHEMBL12565651 0.81 DGKA (0.60) DGKAMGLLDNM1EPHX2PAM
SCHEMBL176410 0.81 DGKA (0.60) DGKAMGLLDNM1EPHX2PAM
SCHEMBL12565648 0.81 DGKA (0.60) DGKAMGLLDNM1EPHX2PAM
SCHEMBL8065894 0.81 DGKA (0.60) DGKAMGLLDNM1EPHX2PAM
SCHEMBL12565650 0.81 DGKA (0.60) DGKAMGLLDNM1EPHX2PAM
SCHEMBL821972 0.81 DGKA (0.60) DGKAMGLLDNM1EPHX2PAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180221498-A1 PH-SENSITIVE LINKERS FOR DELIVERING A THERAPEUTIC AGENT GNT BIOTECH & MEDICALS CORPORATION (TW) 2018-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180221498-A1 PH-SENSITIVE LINKERS FOR DELIVERING A THERAPEUTIC AGENT CD47, CD44, ASIC1 DGKA 2761/4885MGLL 4636/4885HDAC3 1276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.